Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba Extract LI 1370 in MCI
NCT01046292Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- Jan 2010
- Primary completion
- Feb 2015
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Mild Cognitive Impairment (MCI) comparing Ginkgo biloba with Placebo control (2 arms). Primary endpoint: Gait speed at 12 months. Started Jan 2010; status: completed.
02
Drugs
EGb 761
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT01046292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046292.